Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8902
|
pubmed:dateCreated |
1994-5-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
343
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
921
|
pubmed:dateRevised |
2008-8-22
|
pubmed:meshHeading |
pubmed-meshheading:7908384-Ampicillin Resistance,
pubmed-meshheading:7908384-Anti-Bacterial Agents,
pubmed-meshheading:7908384-Clavulanic Acids,
pubmed-meshheading:7908384-Drug Resistance, Microbial,
pubmed-meshheading:7908384-Escherichia coli,
pubmed-meshheading:7908384-Humans,
pubmed-meshheading:7908384-Plasmids,
pubmed-meshheading:7908384-beta-Lactamases
|
pubmed:year |
1994
|
pubmed:articleTitle |
TEM-1 plasmids in the community.
|
pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't
|